Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 1 day agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 10 hours agoLooking at individual holdings, West Pharmaceutical Services Inc (WST) accounts for about 1.73% of...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 1 day agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 10 hours agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 5 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
15 Best Places to Retire in Florida That You’ve Never Heard Of
Insider Monkey via Yahoo Finance· 6 days agoThis article takes a look at the 15 best places to retire in Florida that you’ve never heard of. If...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 5 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...